JOHANNESBURG (Reuters) -South Africa’s Aspen Pharmacare made a full-year loss after tax of 1.1 billion rand ($63 million), it said on Wednesday, citing the impact of a material contractual manufacturing dispute and asset impairments of 4.1 billion rand.
The loss in the year ended June 30 compared to a profit after tax of 4.4 billion rand the previous year.
The company declared a gross dividend of 211 cents per share, down 41%.
($1 = 17.5632 rand)
(Reporting by Nqobile Dludla; editing by Barbara Lewis)
Brought to you by www.srnnews.com
